Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026)

Updated

Definium Therapeutics (DFTX) posted Non Operating Investment Income of -$406,000 for Q2 2026, compared with $36,000 a year earlier.

Analysis

Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Investment Income at Definium Therapeutics was -$384,000; for FY2025, it came in at $330,000.

  • According to Business Quant data, Non Operating Investment Income for the three prior quarters was -$262,000 (Q1 2026), $88,000 (Q4 2025) and $196,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Definium Therapeutics 4.00 Bn 4.00 Bn - -406,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -406,000.00
Mar 31, 2026 -262,000.00
Dec 31, 2025 88,000.00
Sep 30, 2025 196,000.00
Jun 30, 2025 36,000.00
Mar 31, 2025 10,000.00
API Access

Definium Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DFTX&period=max&api_key=YOUR_API_KEY